series-a
Stage
1
Investors
About
Palobiofarma is a biopharmaceutical company that discovers and develops drugs based on selective adenosine receptor modulators targeting rare and orphan diseases.
Explore Palobiofarma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.